Dr. Kallen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S. Greene St.
Baltimore, MD 21201
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematopathology, 2015 - 2017
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pathology-Anatomic and Clinical, 2011 - 2015
Vanderbilt University School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2013 - Present
MD State Medical License 2017 - 2026- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Clinical Trials
- Attitudes and Beliefs and the Steps of HIV Care Start of enrollment: 2008 Apr 01
- Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study Start of enrollment: 2009 Mar 01
- Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- Carvykti CAR T-cell morphology in cellavision peripheral smear reviews.Michael E Kallen, Rima Koka, Djordje Atanackovic
Journal of Hematopathology. 2024-12-01 - Results of an Integrated Phase I/II Prospective Clinical Trial (NEXIS) for Neoadjuvant Anti-PD-L1 (Durvalumab) and Anti-CTLA-4 (Tremelimumab) With Radiation for High-R...Vincent Y Ng, Mario N Sahlani, Jessa D Fogel, Anthony K Chiu, Michael E Kallen
Cureus. 2024-10-01 - Assessment of AI-based computational H&E staining versus chemical H&E staining for primary diagnosis in lymphomas: a brief interim report.Rima Koka, Laura M Wake, Nam K Ku, Kathryn Rice, Autumn LaRocque
Journal of Clinical Pathology. 2024-09-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
